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Abstract
Background: The purpose of our study was to assess the clinical and imaging outcome of autologous matrix-induced
chondrogenesis (AMIC) technique consisting of microfractures followed by the filling of osteochondral lesions of the
talus (OLTs) with a cell-free biphasic collagen-hydroxyapatite osteochondral scaffold (MaioRegen).
Methods: Sixteen patients (eight males, age: 42.6 ± 18.4, range 14–74) with OLT repaired using AMIC technique, with
implantation of MaioRegen, were clinically evaluated through the American Orthopedic Foot and Ankle Society Score
(AOFAS) and a 10-point Visual Analogue Scale (VAS) pain score after a mean follow-up of 30 ± 16.9 months. The MRI
examinations were performed 12 and 24 months after surgery. A paired t-test was applied to compare pre- and
post-operative clinical findings (VAS and AOFAS) and Magnetic resonance observation of cartilage repair tissue
(MOCART) score changes in the follow-up. To assess the correlation between variation of AOFAS and MOCART scores,
the Pearson’s correlation coefficient was calculated.
Results: No complications after surgery were encountered. From pre-operative to post-operative values, there was a
significant (P < 0.001) reduction of mean VAS pain score (6.3 ± 0.9,range: 4–8 and 2.9 ± 1.8,range: 0–6, respectively) and
increase of AOFAS score (60.2 ± 7.8,range: 50–74 and 77.4 ± 16.2,range: 50–100, respectively). Among 16 patients, six
(37%) were not satisfied at the end of follow-up, six (37%) were moderately satisfied and four (25%) were highly
satisfied. The treatment was considered failed in five out of 16 patients (31%). Among them, four (25%) required
re-interventions with implantation of ankle prostheses, whereas one patient was treated with a further AMIC technique
combined with autologous bone graft and platelet-rich plasma. The mean MOCART score was 41.9 ± 14.6 (25–70)
12 months after surgery and 51.9 ± 11.6 (30–70) after 24 months, with a statistically significant increase (P = 0.012).
However, no correlation was seen between AOFAS and MOCART changes (r = 0.215, p = 0.609).
Conclusion: The high rates of treatment failure encountered in our study using MaioRegen need to be confirmed by
larger studies and should induce the scientific community questioning the reliability of this biomimetic scaffold for the
treatment of OLTs.
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Background
Osteochondral lesions of the talus (OLT) are defects of
the chondral layer and subchondral bone, which com-
monly affect the talar articular surface. Their etiology re-
mains unclear, although a relation with post-traumatic
instability of the ankle has been postulated [1]. OLT may
determine a variable clinical picture, ranging from inci-
dental diagnosis in asymptomatic patients to severe pain
and limitation of daily activities [2]. When incidentally dis-
covered, OLTs may be treated conservatively with rest,
nonsteroidal anti-inflammatory drugs, and intra-articular
injections of platelet-rich plasma or hyaluronic acid, al-
though conservative therapies are usually ineffective
thereby requiring surgery [3]. To date, several surgical
approaches have been proposed to treat OLT, including
osteochondral grafting, debridement, microfractures an
chondrocyte implantation, even though there is no con-
sensus on the best treatment choice [4].
Autologous matrix-induced chondrogenesis (AMIC) is
a procedure consisting of microfractures followed by
osteochondral defect filling using a scaffold that allows
the regeneration of articular cartilage from bone marrow
mesenchymal stem cells [5]. For reconstruction, tissue
engineering should consider to support the regeneration
of both cartilage and subchondral bone. To date, almost
all of the scaffolds present in the market are homoge-
neous and cannot balance chondrogenesis and osteogen-
esis simultaneously for repairing osteochondral defects
[6]. Therefore, new biphasic scaffolds with different
layers mimicking the structures of osteochondral tissues
have been designed to close this chasm. The MaioRegen
is a cell-free biometic scaffold, which with its structure
can address both the chondral layer and the underlying
subchondral bone. Furthermore, MaioRegen is im-
planted with a one-step technique, which can theo-
retically decreases surgical time, costs and morbidity.
Controversial results have been reported for osteochon-
dral defect repair in the knee [7, 8].
After surgery, conventional radiographs and computed
tomography allows evaluating only the bony component
without providing any information regarding cartilage
layer. Conversely, magnetic resonance imaging (MRI) is
a radiation-free modality, which is considered the refer-
ence standard to assess the osteochondral lesions after
surgical repair [9]. The Magnetic Resonance Observation
of Cartilage Repair Tissue (MOCART) score is conven-
tionally used to grade cartilage regeneration over time
[10]. It was introduced to evaluate the repair tissue after
treatment of osteochondral lesions of the knee [10–12].
Nevertheless, several authors have used this score in the
ankle to monitor the healing of OLTs repaired with
AMIC technique achieving controversial results in the
correlation between clinical scores and MOCART values
after surgery [13–17].
The purpose of our study was to assess the clinical
and MRI outcome of AMIC technique performed with a
cell-free biphasic collagen-hydroxyapatite osteochondral
scaffold for the treatment of OLT. Moreover, we
evaluated the correlation existing between clinical and




This retrospective study was approved by Ospedale San
Raffaele (Milano, Italy) Ethical Committee (Protocol
#RM106). All individuals involved in this study provided
written consent to use their clinical and imaging data for
research purposes. This study has been conducted ac-
cording to the principles expressed in the Declaration of
Helsinki.
All OLTs were diagnosed using MRI after being sus-
pected based on clinical findings. Inclusion criteria for
the surgical procedure were symptomatic OLTs classified
as type II or IIA (>1.5 cm2 in area and >5 mm deep, re-
spectively) [18, 19], with history of failed conservative
treatment. Exclusion criteria were: history of ankle
fracture, hemophilia, pregnancy, septic ankle arthritis,
rheumatic diseases and neuromuscular disorders.
AMIC technique
All patients were treated by two orthopedic surgeons
specialized in ankle surgery (N.M. and A.B.). Lesions
were approached through a medial malleolar osteotomy.
The line of osteotomy was performed at the junction of
the medial plafond to obtain adequate exposure of the
lesion. The site was prepared by creating a defect with
stable shoulders where the scaffold was placed. Micro-
fractures were performed using a chondral pick. The
lesion was templated using an aluminum foil, and the
scaffold (MaioRegen, FinCeramica Faenza, Faenza, Italy)
was cut to the exact size of the defect and implanted by
press-fitting. This osteochondral biomimetic scaffold has
a porous three-dimensional composite three-layer struc-
ture that mimics the osteochondral anatomy [20]. After
the scaffold was implanted, osteotomy was fixed with
two malleolar screws that were inserted through
predrilled holes. Patients were immobilised in a non-
weight-bearing plaster cast for 4 weeks; the duration of
casting was extended depending on radiological consoli-
dation of the malleolar osteotomy. After removal of the
cast the patients started light weight bearing with two
crutches for 4 weeks.
Clinical evaluation
The clinical evaluation was performed through the
American Orthopedic Foot and Ankle Society Score
(AOFAS) (poor <70 points, fair 70–79 points, good 80–89
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points, excellent 90–100 points) [21]. The AOFAS score is
a clinician-administered questionnaire, which includes
three areas: pain, function and alignment. Although
this score was developed specifically to assess foot or
ankle problems, some aspects of quality of life can be
evaluated with this outcome measure. A 10-point Vis-
ual Analogue Scale (VAS) for the assessment of pa-
tient’s pain was also performed. Clinical evaluation
was made up to 15 days before surgery and after
treatment. The validated Italian version of Foot Func-
tion Index (FFI) [22] was also applied but only for
post-operative evaluation, as this score was validated
after that most of our patients were surgically treated.
The FFI consists of 18 items grouped into two sub-
scales: pain (FFI-P) and disability (FFI-D). Each of the
two subscales is calculated as the sum of the items
included. Scores are then transformed to a 0–100
scale. The measure generates two separate scores
(FFI-P, FFI-D) where the higher the score, the worst
the health state.
At the end of follow-up, each patient was asked to
express his overall satisfaction as: (i) not satisfied; (ii)
moderately satisfied; (iii) highly satisfied. The surgical
intervention was considered failed in case of persistent
pain with VAS > 4 and the patients needed to be re-
operated for residual pain.
MRI protocol and image interpretation
All MRI scans of the ankle were performed on one of two
1.5 T MRI scanners (Avanto and Espree, Siemens Medical
Solution, Erlangen, Germany) using a dedicated extremity
coil. The MRI examinations were performed 12 and
24 months after surgery in a subset of patients (n = 8). In
our MRI protocol the following sequences were included:
sagittal T1-weighted turbo spin-echo, sagittal short time
inversion recovery, axial T1-weighted turbo spin-echo,
axial proton density-weighted fat-saturated, coronal pro-
ton density-weighted fat-saturated, coronal T2-weighted
turbo spin-echo (slice thickness 3 mm).
One musculoskeletal radiologist with 12 years’ experi-
ence reviewed the MRI scans of the ankle performed
after treatment to evaluate the MOCART score. In our
institution, radiologists and orthopaedic surgeons, are
trained in the use of MOCART score since the cases of
OLTs surgically repaired are frequently discussed in
multidisciplinary sessions. This score is composed of
nine variables, which are used to describe cartilage re-
pair tissues after treatment: (i) defect filling, (ii) cartilage
interface, (iii) surface, (iv) adhesions, (v) structure, (vi)
signal intensity, (vii) subchondral lamina, (viii) subchon-
dral bone, (ix) effusion [10]. A score is given for all
variables and the total score ranges from 0 (worse
condition) to 100 points (best condition).
Statistical analysis
Nomality of data distribution was verified. A paired t-
test was applied to compare pre- and post-operative
clinical findings and MOCART changes in the follow-up.
The t-test was used after checking normal distribution
of data. To assess the correlation between variation of
AOFAS and MOCART scores, the differences between
pre- and post-treatment values (change in AOFAS and
change in MOCART) were calculated. Then, the Pear-
son’s correlation coefficient was calculated to better
understand the relationship between clinical findings
and MRI features and the role of imaging in monitoring
these patients. Statistical analysis was performed using
SPSS® software (v. 23, IBM, Armonk, New York, NY). A
P-value lower than 0.05 was considered as statistically
significant, where appropriate.
Results
Among 62 patients with OLT, 16 were treated with the
AMIC technique using the biomimetic osteochondral
scaffold MaioRegen and met the inclusion criteria,
thereby being enrolled in this study. Thus, our study
population included 16 patients (8 males, 8 females; age:
42.6 ± 18.4, range 14–74) with OLT repaired using the
AMIC technique with MaioRegen implantation between
January 2013 and June 2016. The patients had a mean
body mass index of 26.3 ± 5.2 (range: 19.1–40.5).
No complications after surgery were encountered.
Mean follow-up of our patients was 30 ± 16.9 months
(range: 10–52).
Pain decrease in terms of VAS was observed in 15/16
patients (94%) while it remained unchanged in one pa-
tient (6%). There was a significant (P < 0.001) reduction
of mean VAS pain score from pre-operative values
(6.3 ± 0.9, range: 4–8) to post-operative values
(2.9 ± 1.8, range: 0–6).
Pre-operative AOFAS score was poor in 15/16 patients
(94%) whereas it was fair in one patient (6%). After sur-
gery, the AOFAS score was poor in six patients (37%),
fair in two patients (12%), and excellent in the remaining
eight patients (50%). We found a statistically significant
increase (P < 0.001) between pre-operative (60.2 ± 7.8,
range: 50–74) and post-operative (77.4 ± 16.2, range:
50–100) AOFAS scores.
Compared to baseline, at the end of follow-up the
AOFAS scores improved in 11/16 patients (69%),
remained unchanged in 4/16 patients (25%) and worsened
in one patient (6%). The mean post-operative FFI-D and
FFI-P values were 38.2 ± 29.1 and 31.1 ± 27.1,
respectively.
Among 16 patients, six (37%) were not satisfied at the
end of follow-up, six (37%) were moderately satisfied,
and four (25%) were highly satisfied.
Albano et al. BMC Musculoskeletal Disorders  (2017) 18:306 Page 3 of 7
The treatment was considered failed in five out of 16
patients (31%). Among them, four (25%) required re-
interventions with implantation of ankle prostheses
(HemiCAP®), whereas one patient was treated with a fur-
ther AMIC technique combined with autologous bone
graft and platelet-rich plasma.
The mean MOCART score was 41.9 ± 14.6 (25–70)
12 months after surgery and 51.9 ± 11.6 (30–70) after
24 months, with an improvement of 24% and a statisti-
cally significant increase (P = 0.012). However, no correl-
ation was seen between change in AOFAS and change in
MOCART (r = 0.215, p = 0.609). The MOCART score
improved in 5/8 patients (63%), whereas it remained
unchanged in 3 patients, and complete filling of the
osteochondral defect at the level of the surrounding car-
tilage was observed in 3/8 patients (37%). Figure 1 shows
a representative case from our series.
Discussion
Our main finding was that the AMIC technique with
MaioRegen implant failed in 31% of our patients who
required re-intervention with implantation of ankle
prostheses, although we found a progressive signifi-
cant improvement of AOFAS, VAS and MOCART
scores overall.
It is not easy to compare our results to those of previous
studies focusing on other surgical treatments of OLTs,
since different criteria for considering successful outcomes
can be encountered. Chuckpaiwong et al. studied 105 pa-
tients with OLT treated with arthroscopic debridement
with osteochondral bone stimulation (microfracture) [23].
They observed a successful rate of 70% with all unsuccess-
ful treatments involving patients with lesions greater than
15 mm [23]. Ferkel and colleagues evaluated the long-
term (average follow-up: 71 months) results of patients
Fig. 1 Fifty-three year old woman with OLT repaired using AMIC technique with MaioRegen. Preoperative (a) and postoperative (b) conventional
radiographs show a medial talar dome osteochondral lesion (headarrows). Coronal T2-weighted turbo spin-echo images at 12 months (c) and
24 months (d) show complete filling of the osteochondral defect of the medial talar dome (headarrows). Conventional radiograph performed after
re-intervention (e) with implantation of talar dome HemiCAP® (arrow)
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with chronic symptomatic OLT treated predominantly by
arthroscopic excision and drilling ankle. They reported
good to excellent results in 64% of patients based on the
modified Weber score, and 72% of the patients with the
Alexander score. The average AOFAS score was 84 in
their series in line with other studies on arthroscopic
treatment of OLT [24]. Autologous chondrocyte implant-
ation has shown to be an effective procedure for the treat-
ment of OLT with excellent or good clinical results in 90%
of patients on a 10-year follow-up study by Giannini et al.
[25]. Regarding the arthroscopic treatment with bone
marrow-derived mesenchymal stem cell transplantation,
Giannini and colleagues demonstrated the good clinical
results at 48 months’ follow-up with 78% of patients being
able to resume previous sports level [17].
Over the last years, several studies have focused on the
treatment of osteochondral lesions with procedures that
induce the restoration of articular surface using tissue-
engineering technology and scaffold implantation [7, 20,
26–31]. MaioRegen is a multilayered biomimetic scaffold
consisting of collagen type I and magnesium-
hydroxyapatite, which should induce cartilage and bone
regeneration [26]. In previous studies, mainly evaluating
the repair of osteochondral knee defects, the use of
MaioRegen has shown to lead to promising clinical re-
sults [7, 20, 30, 31]. Nevertheless, Christensen et al. have
arisen concerns about the use of this scaffold for the
treatment of osteochondral lesions, suggesting using it
with caution [8]. Although they found a clinical im-
provement in patients with osteochondral lesions of
femoral condyle, patella and talus, they underlined the
poor results achieved in terms of subchondral bone and
cartilage restoration. As well as with MRI, they moni-
tored patients with computed tomography that allowed
them to better demonstrate the insufficient bone forma-
tion within the osteochondral defect [8]. Similarly to
them, we found an improvement of clinical findings after
surgery with good post-operative FFI values and a sig-
nificant increase of AOFAS and decrease of VAS scores.
However, we encountered poor patients’ satisfaction and
high rates of treatment failure. Thus, we support the hy-
pothesis of Christensen and colleagues that the initial
clinical improvement of patients with osteochondral le-
sions treated with MaioRegen could be related to the re-
moval of the affected subchondral bone rather than
cartilage repair or bone restoration, since in osteochon-
dral lesions pain arises from subchondral bone [8]. The
incomplete recovery of both cartilage layer and subchon-
dral bone after surgery could probably lead to a subse-
quent worsening of these structures status.
In a previous study, Valderrabano et al. reported an
adapted AMIC technique to treat OLTs, which included
the addiction of mesenchymal stem cells-rich autologous
cancellous bone from the iliac crest to improve the
reconstruction of bony defect [10]. Twenty-four months
after surgery, they obtained a significant improvement in
AOFAS and VAS scores. They also found a complete filling
of the osteochondral defect at the level of the surrounding
cartilage in MRI scans performed in 35% of patients. We
saw a complete filling of the defect in 37% of our patients,
in line with the results of the study of Valderrabano [13],
even without the use of any mesenchymal cell
supplementation.
Kubosch et al. demonstrated a significant improvement
in post-operative clinical and imaging findings in 17 pa-
tients with OLTs treated with autologous subchondral
cancellous bone graft and AMIC [14]. After a mean follow
up of 39.5 ± 18.4 months, they also found a significant
correlation between MOCART and AOFAS score [14]. In
our study, MOCART score showed improvement of im-
aging findings after surgery. However, the increase of
MOCART score was not correlated with AOFAS score
changes. Similarly to our results, Aurich et al. did not find
any correlation between MOCART and clinical scores
after treatment with AMIC technique for OLTs [16]
whereas, as we reported above, Kubosch et al. found a sig-
nificant correlation [14]. As suggested by Christensen and
colleagues, a thorough radiological follow-up for patients
with OLTs repaired using biomimetic scaffolds is recom-
mended [8]. Nevertheless, although MRI can be consid-
ered useful to identify eventual complications after
surgical repair of OLTs, the assessment of the cartilage
status with standard sequences may be challenging. The
MOCART score was specifically designed to evaluate
chondral repair of the knee, where cartilage thickness and
joint space is larger. In the ankle, the cartilage layer and
the joint space is smaller compared to the knee, thus mak-
ing the use of MOCART suboptimal in this setting. Thus,
other available options, which deserve to be considered in
future studies on the biological cartilage repair, are the de-
layed Gadolinium-enhanced MRI of cartilage [32] and
MRI-specific sequences [12, 33, 34]. Among them, the
most promising are T1 rho imaging, T2 mapping,
diffusion-weighted imaging and diffusion tensor imaging,
which might help to better evaluate the cartilage ultra-
structure after surgery [12, 33, 34].
Some limitations should be taken into account. First,
this is a retrospective study with relatively small number
of patients. Second, the MRI protocol did not include
three-dimensional fat-suppressed gradient echo acquisi-
tion that may have improved the reliability of the
MOCART score. However, a similar protocol was also
used in previous papers on the topic [35]. Then, we have
not investigated the reproducibility of the MOCART
score. However, recently MOCART score has not shown
to be reproducible for the evaluation of surgical repaired
OLTs [36]. Last, another limitation of the work might be
the absence of control group, although our aim was
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mainly to evaluate clinical efficacy and imaging outcome
over time.
Conclusions
In conclusion, we found a high rate of failures in pa-
tients treated using MaioRegen for OLTs. However, this
data needs to be confirmed by larger studies to better
understand the applicability of this biomimetic scaffold
for the treatment of OLTs. Although a thorough radio-
logical follow-up is recommended in patients with
surgically-treated OLTs, the MOCART score does not
correlate with the clinical data.
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